Read-Gene (Poland)

Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer

Andrew Tutt, Judy E. Garber, Bella Kaufman et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 416 citations · Full text

Medicine, Oncology, Pharmacology +15

Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer

Marcin Lener, Rodney J. Scott, Anna Wiechowska–Kozłowska et al. · Cancer Research and Treatment · 2015 · 115 citations · Full text

Medicine, Nutritional Sciences, Oncology +14

Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation.

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · Journal of Clinical Oncology · 2020 · 110 citations

Medicine, Oncology, Pharmacology +16

Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence

Grzegorz Sukiennicki, Wojciech Marciniak, Magdalena Muszyńska et al. · PLoS ONE · 2019 · 66 citations · Full text

Medicine, Genetics, Oncology +13